Item Number: EURICAND
Eurican DHPPi Presentation 10 Dose.
A combined live freeze-dried vaccine against canine distemper, infectious canine hepatitis, canine parvovirus and canine parainfluenza virus type 2. Each 1-ml dose of vaccine contains attenuated canine distemper virus, at least 104.0 CCID50, attenuated canine adenovirus (CAV2), at least 102.5 CCID50, attenuated canine parvovirus, at least 104.9 CCID50, attenuated canine parainfluenza type 2 virus, at least 104.7 CCID50
Dogs and puppies from 8 weeks of age:
Active immunization against distemper to reduce mortality and clinical signs; against infectious canine hepatitis to prevent clinical signs; against parvovirus to prevent clinical signs and reduce mortality and viral excretion; and against parainfluenza type 2 infections to reduce clinical signs and viral excretion.
Onset of immunity: 2 weeks after completion of the primary vaccination course.
Duration of immunity: 1 year.
Dosage and administration
Reconstitute the vaccine with Eurican L using a clean sterile syringe. Use the vaccine immediately after reconstitution of the freeze-dried pellet. Apply usual aseptic procedures. Use sterile and/or disinfectant-free equipment for injection purposes.
Administer by subcutaneous injection. The following vaccination schedule is recommended:
1st injection: from 8th week of age.
2nd injection: 3 to 5 weeks later, from 12th week of age.
Booster injections should be given annually thereafter.
Contra-indications, warnings, etc
For animal treatment only.
The CAV 2 and CPV vaccinal strains may be shed from vaccinated animals for a number of days following vaccination. However, due to the absence of demonstrable pathogenicity of these strains, it is not necessary to keep vaccinated animals separated from non-vaccinated animals.
Do not mix with any other veterinary medicinal product except Eurican L.
Vaccination may occasionally cause hypersensitivity reactions in some animals. In such cases symptomatic treatment should be provided. In rare cases, immediately after the injection, slight and transient pain may occur at the injection site. Slight swelling (<4cm) at the injection site may be observed after vaccination. Such swellings will resolve in most animals within 4-5 days. Some animals may also show slight dullness during the first three days post vaccination.
Can be used during pregnancy. In the absence of data from studies in seronegative bitches, the vaccine should only be used in pregnant bitches which have previously been vaccinated before pregnancy.
Safety and efficacy data are available which demonstrate that this vaccine can be reconstituted in Eurican L. No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above.
A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
In case of accidental self-injection, seek medical advice immediately and show the package insert or label to the physician.
Store and transport between +2°C and +8°C, protected from light. Do not freeze.
Use immediately after reconstitution.
Keep out of the reach and sight of children.
Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.
Packs containing 10 single dose vials.